| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |